Course Details
- Discussion on the clinical course of IPF and the benefits of early diagnosis and treatment.
- Discussion on the 2 replicate clinical trials conducted to evaluate the efficacy and safety of nintedanib in patients with Idiopathic Pulmonary Fibrosis.
- How to screen and monitor patients in the context of IPF, other fibrosing ILDs with a progressive phenotype, and SSc-ILD.